Q2 2020 Genocea Biosciences Inc Earnings Call Transcript
Good morning, and welcome to the Genocea Second Quarter 2020 Q2 Conference Call. (Operator Instructions) Please be advised the call is being recorded at the company's request. At this time, I'd like to turn the call over to Dan Ferry of LifeSci Advisors. Please proceed.
Thank you, operator, and good morning, everyone. Earlier today, we issued a press release that outlines the topics we plan to discuss today. This release is available at genocea.com under the Investors tab. During the call today, Chip Clark, President and CEO, will provide a brief corporate update and the company's Chief Financial Officer, Diantha Duvall, will review the financial results. After the prepared remarks, we will open up the call for Q&A and Chip, Diantha, Tom Davis, Genocea's Chief Medical Officer and Jessica Flechtner, Genocea's Chief Scientific Officer, will then be available to answer your questions.
Before we begin, I would like to remind everyone that statements made during this conference call
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |